NCT07169227View on ClinicalTrials.gov

Lidocaine, Paracetamol, and Dexmedetomidine for Rocuronium Injection Pain

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Propofol Injection PainRocuronium Injection Pain
Interventions
DRUG

Lidocaine %2 ampoule

Patients who were administered 40 mg lidocaine.

DRUG

Dexmedetomidine

Patients who were administered 0.25 mg/kg dexmedetomidine.

DRUG

paracetamol

Patients who were administered 50 mg paracetamol.

Trial Locations (1)

Unknown

Baskent University, Adana

All Listed Sponsors
lead

Baskent University

OTHER